Heterozygous knock-out of ET(B) receptors induces BQ-123-sensitive hypertension in the mouse

Hypertension

Volumn 36, Issue 6, 2000, Pages 1002-1007

  Berthiaume, Nathalie ^a   Yanagisawa, Masashi ^b   Labonté, Julie ^a   D'Orléans Juste, Pedro ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Arterial pressure; Mice; Receptors, genetic

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE];

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; HETEROZYGOSITY; HYPERTENSION; ISOTOPE LABELING; KNOCKOUT MOUSE; LETHALITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR GENE;

EID: 0033675513     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.36.6.1002     Document Type: Article

References (20)

1. Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice
2. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice
3. 2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons
4. Targeting the genes of angiotensin receptors
5. 2 receptor knock-out mice
6. Murine double nullizygotes of the angiotensin types 1(A) and 1(B) receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes
7. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1
8. Renal sympathetic nerve activity in mice: Comparison between mice and rats and between normal and endothelin-1 deficient mice
9. Biological profiles of highly potent novel endothelin antagonists selective for the ET(A) receptor
10. 11,15]-endothelin-1 (8-21), IRL-1620, for the ET(B) receptor
11. Biochemical and pharmacological profile of a potent and selective endothelin-B receptor antagonist, BQ-788
12. SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist
13. Clearance of circulating endothelin-1 by ET(B) receptors in rats
14. ET(B) receptor and nitric oxide synthase blockade induce BQ-123-sensitive pressor effects in the rabbit
15. Renal and hemodynamic effects of endothelin in anaesthetized dogs
16. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade
17. Absence of ET(B)-mediated contraction in piebald-lethal mice
18. ET(B) mediated regulation of extracellular levels of endothelin-1 in cultured human endothelial cells
19. Elevation of blood pressure by genetic and pharmacological disruption of the ET(B) receptor in mice
20. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease